Evaluating Local Bupivacaine Injection for Pain Relief After Prone Percutaneous Nephrolithotomy Surgery

What this Trial Is About

Researchers are assessing the effectiveness of using local anesthetic infiltration along the nephrostomy tract to control pain after prone percutaneous nephrolithotomy surgery. This randomized controlled trial compares standard systemic postoperative pain treatment alone versus standard treatment combined with infiltration of 20 mL of 0.25% bupivacaine. The goal is to find out if this local infiltration reduces pain and the need for additional pain medication after surgery. Participants will be randomly assigned to one of two groups. One group will receive standard postoperative pain relief with intravenous tramadol and paracetamol, while the other group will receive the same systemic analgesia plus local infiltration of bupivacaine along the nephrostomy tract at the end of surgery. Rescue opioid analgesia is available if needed for both groups. The study tracks outcomes during the first 24 hours after surgery. Participants will have their pain levels measured using the Visual Analog Scale at 1, 6, 12, and 24 hours post-surgery. Additional assessments include time to first need for rescue analgesia, total opioid use in 24 hours, need for rescue analgesia, time to mobilization, length of hospital stay, and any treatment-related complications. The study lasts through the immediate postoperative period with close monitoring of pain and recovery indicators.

Nephrostomy Tract Infiltration for Pain Control After PCNL